These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30999735)

  • 1. Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis.
    Iranpour S; Hosseinzadeh A; Alipour A
    Epidemiol Health; 2019; 41():e2019011. PubMed ID: 30999735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Bolivian Leishmania braziliensis Cutaneous and Mucosal Leishmaniasis.
    Soto J; Gutiérrez P; Soto P; Paz D; Cayhuara E; Molina C; Sánchez M; Berman J
    Am J Trop Med Hyg; 2022 Jan; 106(4):1182-1190. PubMed ID: 35385826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions to treat cutaneous leishmaniasis in children: A systematic review.
    Uribe-Restrepo A; Cossio A; Desai MM; Dávalos D; Castro MDM
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006986. PubMed ID: 30550538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American tegumentary leishmaniasis in Brazil: a critical review of the current therapeutic approach with systemic meglumine antimoniate and short-term possibilities for an alternative treatment.
    Carvalho SH; Frézard F; Pereira NP; Moura AS; Ramos LMQC; Carvalho GB; Rocha MOC
    Trop Med Int Health; 2019 Apr; 24(4):380-391. PubMed ID: 30681239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disseminated Leishmaniasis, a Severe Form of Leishmania braziliensis Infection.
    Machado PRL; Lago A; Cardoso TM; Magalhaes A; Carvalho LP; Lago T; Carvalho AM; Costa R; Carvalho EM
    Emerg Infect Dis; 2024 Mar; 30(3):510-518. PubMed ID: 38407142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison Of Efficacy Of Miltefosine Versus Meglumine Antimonate In The Treatment Of Cutaneous Leishmaniasis.
    Mohammad N; Sagheer F; Paracha MM; Khan AQ; Naseem S; Wasim M
    J Ayub Med Coll Abbottabad; 2022; 34(4):849-853. PubMed ID: 36566412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial.
    Mendes L; Guerra JO; Costa B; Silva ASD; Guerra MDGB; Ortiz J; Doria SS; Silva GVD; de Jesus DV; Barral-Netto M; Penna G; Carvalho EM; Machado PRL
    Int J Infect Dis; 2021 Feb; 103():358-363. PubMed ID: 33253864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
    de Morais-Teixeira E; Aguiar MG; Soares de Souza Lima B; Ferreira LA; Rabello A
    J Antimicrob Chemother; 2015 Dec; 70(12):3283-90. PubMed ID: 26346991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of
    Tunalı V; Harman M; Çavuş İ; Zorbozan O; Özbilgin A; Turgay N
    Turkiye Parazitol Derg; 2022 May; 46(2):97-101. PubMed ID: 35604185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming the Challenge; In Vivo Efficacy of Miltefosine for Chronic Cutaneous Leishmaniasis.
    Tunalı V; Harman M; Çavuş İ; Gündüz C; Özbilgin A; Turgay N
    Acta Parasitol; 2021 Jun; 66(2):354-360. PubMed ID: 32996014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial.
    Tayyebi M; Darchini-Maragheh E; Layegh P; Kiafar B; Goyonlo VM
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009241. PubMed ID: 33739976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miltefosine in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil: a randomized and controlled trial.
    Machado PR; Ampuero J; Guimarães LH; Villasboas L; Rocha AT; Schriefer A; Sousa RS; Talhari A; Penna G; Carvalho EM
    PLoS Negl Trop Dis; 2010 Dec; 4(12):e912. PubMed ID: 21200420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miltefosine for new world cutaneous leishmaniasis.
    Soto J; Arana BA; Toledo J; Rizzo N; Vega JC; Diaz A; Luz M; Gutierrez P; Arboleda M; Berman JD; Junge K; Engel J; Sindermann H
    Clin Infect Dis; 2004 May; 38(9):1266-72. PubMed ID: 15127339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
    Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
    Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.
    Castro MDM; Cossio A; Velasco C; Osorio L
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005515. PubMed ID: 28379954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for American cutaneous and mucocutaneous leishmaniasis: a systematic review update.
    Reveiz L; Maia-Elkhoury AN; Nicholls RS; Romero GA; Yadon ZE
    PLoS One; 2013; 8(4):e61843. PubMed ID: 23637917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
    Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
    Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of Miltefosine in Children and Adults with Cutaneous Leishmaniasis.
    Castro MD; Gomez MA; Kip AE; Cossio A; Ortiz E; Navas A; Dorlo TP; Saravia NG
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of cutaneous leishmaniasis: a review.
    Arana B; Rizzo N; Diaz A
    Med Microbiol Immunol; 2001 Nov; 190(1-2):93-5. PubMed ID: 11770121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Miltefosine Failure and Spontaneous Resolution of Cutaneous Leishmaniasis braziliensis.
    Joseph S; Whitman TJ; Buckner FS; Cogen AL
    Am J Trop Med Hyg; 2021 May; 105(1):142-143. PubMed ID: 33970891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.